Eylea Shows Sustained Improvements In BCVA Vs. Laser Photocoagulation | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Monday, July 21, 2014

Email

Comments

Ocular Surgery News

Data from the phase 3 VIVID-DME trial indicate that aflibercept injection provided sustained improvements in best corrected visual acuity from baseline at 2 years compared with laser photocoagulation in patients with diabetic macular edema.

The Schirmer postanesthesia test:
1. Measures reflex tear secretion
2. Measures basal tear secretion
3. Should be used with at least 4 drops of topical anesthetic
4. Should be performed before drying the cul-de-sac
Check The Answer

$TS-610/310 Tabletop Refraction System$
TS-610/310 Tabletop Refraction System
The TS-610 and TS-310 are tabletop ... view product
PanoCam™ LT Wide-field Digital Imaging System
The PanoCam LT represents the first ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us